Overview
Symptomatic HFE-related hemochromatosis is a genetic condition where the body absorbs too much iron from food. Over time, this excess iron builds up in organs such as the liver, heart, pancreas, and joints, causing damage. The disease is caused by mutations in the HFE gene, most commonly the C282Y mutation. While many people carry these mutations, only a portion develop the full symptomatic form of the disease, which means they have actual organ damage or significant symptoms from iron overload. Common symptoms include chronic fatigue, joint pain (especially in the hands), darkening or bronzing of the skin, liver problems (including cirrhosis), diabetes, heart problems, and sexual dysfunction due to hormonal changes. Men tend to develop symptoms earlier than women, often between ages 40 and 60, because women lose iron through menstruation and pregnancy, which delays iron buildup. The good news is that symptomatic hemochromatosis is one of the most treatable genetic conditions. The main treatment is therapeutic phlebotomy, which is essentially regular blood removal similar to blood donation. This lowers iron levels in the body and can prevent further organ damage. When caught early and treated consistently, many people with this condition can live normal, healthy lives. However, if organ damage has already occurred — particularly liver cirrhosis — some effects may not be fully reversible. Regular monitoring and lifelong management are essential.
Key symptoms:
Chronic fatigue and weaknessJoint pain, especially in the knuckles and fingersDarkening or bronzing of the skinLiver enlargement or liver diseaseDiabetes or high blood sugarHeart problems such as irregular heartbeat or heart failureLoss of sex drive or erectile dysfunctionAbdominal painMemory problems or difficulty concentrating (brain fog)Unexplained weight lossHair lossMood changes or depressionShortness of breathThyroid problems
Clinical phenotype terms (44)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
1 eventRennes University Hospital — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Symptomatic form of HFE-related hemochromatosis.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Specialists
View all specialists →No specialists are currently listed for Symptomatic form of HFE-related hemochromatosis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Symptomatic form of HFE-related hemochromatosis.
Community
No community posts yet. Be the first to share your experience with Symptomatic form of HFE-related hemochromatosis.
Start the conversation →Latest news about Symptomatic form of HFE-related hemochromatosis
No recent news articles for Symptomatic form of HFE-related hemochromatosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How much iron overload do I currently have, and has it caused any organ damage?,How often will I need phlebotomy treatments, and how long will the initial treatment phase last?,Should my family members (siblings, children, parents) be tested for hemochromatosis?,Do I need screening for liver cancer or other complications, and how often?,Are there specific foods, supplements, or medications I should avoid?,Will my joint pain improve with treatment, or do I need additional management for that?,What ferritin and transferrin saturation levels are we targeting for my maintenance phase?
Common questions about Symptomatic form of HFE-related hemochromatosis
What is Symptomatic form of HFE-related hemochromatosis?
Symptomatic HFE-related hemochromatosis is a genetic condition where the body absorbs too much iron from food. Over time, this excess iron builds up in organs such as the liver, heart, pancreas, and joints, causing damage. The disease is caused by mutations in the HFE gene, most commonly the C282Y mutation. While many people carry these mutations, only a portion develop the full symptomatic form of the disease, which means they have actual organ damage or significant symptoms from iron overload. Common symptoms include chronic fatigue, joint pain (especially in the hands), darkening or bronzi
How is Symptomatic form of HFE-related hemochromatosis inherited?
Symptomatic form of HFE-related hemochromatosis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Symptomatic form of HFE-related hemochromatosis typically begin?
Typical onset of Symptomatic form of HFE-related hemochromatosis is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Symptomatic form of HFE-related hemochromatosis?
Yes — 1 recruiting clinical trial is currently listed for Symptomatic form of HFE-related hemochromatosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.